Dextroamphetamine controlled release (Cingulate Therapeutics)

N/A

Report date: 2024/04/28 17:06:39

Base Information

Drug NameDextroamphetamine controlled release (Cingulate Therapeutics)
Drug Alias NameDextroampfetamine sulphate (Cingulate Therapeutics)CTX-1302
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsAttention Deficit Disorder with Hyperactivity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCingulate Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesCingulate Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with Hyperactivity
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A